Skip to main content
. 2006 Feb 7;61(4):331–336. doi: 10.1136/thx.2005.051508

Table 2 Primary malignancies found in the study population.

Primary malignancy No of patients No of ever smokers (% by malignancy type)
Group 1
 Head/neck 11 9 (82)
Group 2
 Bladder 12 9 (75)
 Breast 64 41 (64)
 Cervix 1 0 (0)
 Oesophagus 2 1 (50)
 Ovary 2 1 (50)
 Prostate 15 11 (73)
 Subtotal 96 63 (67)
Group 3
 Colon 15 10 (67)
 Rectum 4 2 (50)
 Liver 1 1 (100)
 Carcinoid 1 1 (100)
 Adrenal 1 0 (0)
 Kidney 6 1 (17)
 Uterus 6 3 (50)
 Subtotal 34 18 (53)
Group 4
 Thymus 1 0 (0)
 Melanoma 8 6 (75)
 Sarcoma* 7 5 (71)
 Testes 4 3 (75)
 Kaposi's sarcoma 2 2 (100)
 Subtotal 22 16 (73)
Total† 151 101 (67)

*Includes one case each of benign metastasising leiomyosarcoma, osteogenic sarcoma, uterine sarcoma, synovial cell sarcoma, and chondrosarcoma, as well as two cases of unspecified sarcomas.

†All tumour types were analysed individually. Because some patients had more than one primary tumour, the sum of all figures in a given column may exceed that reported as the total.